Computer-aided sperm analysis (CASA) technology is 7 years old. Over 1
20 papers have been written that verify the technology or apply it in
basic and clinical studies. Most of the technical problems with CASA,
such as the dependence of velocity on video frame rate, inaccuracy of
count and percent motility for low- and high-concentration specimens,
parameter dependence on the number of frames analyzed, sensitivity of
the subjective threshold setting, confusion over the presence of debri
s, and different implementations of algorithms across instruments, sti
ll persist. A critical review of the literature reveals that no standa
rd practices are followed within or across instruments. Moreover, no s
tandards have been embraced or recommended by professional societies.
Despite its potential to provide objective measurements of specimen an
d individual sperm parameters, and to automate the laboratory semen an
alysis, the promise of CASA has not been fulfilled. Unless laboratory
medicine defines instrument performance and laboratory standards and c
ooperates with industry to achieve these goals, CASA technology may re
main a research curiosity. This outcome is especially worrisome in the
context of increasing requirements for laboratory accuracy, precision
, standardization, and accreditation under the Clinical Laboratory Imp
rovement Act of 1988.